Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 262

1.
2.

Effects of modafinil on wakefulness and executive function in patients with narcolepsy experiencing late-day sleepiness.

Schwartz JR, Nelson MT, Schwartz ER, Hughes RJ.

Clin Neuropharmacol. 2004 Mar-Apr;27(2):74-9. Erratum in: Clin Neuropharmacol. 2004 May-Jun;27(3):152.

PMID:
15252267
4.

Dosing regimen effects of modafinil for improving daytime wakefulness in patients with narcolepsy.

Schwartz JR, Feldman NT, Bogan RK, Nelson MT, Hughes RJ.

Clin Neuropharmacol. 2003 Sep-Oct;26(5):252-7.

PMID:
14520165
6.

The efficacy and safety of armodafinil as treatment for adults with excessive sleepiness associated with narcolepsy.

Harsh JR, Hayduk R, Rosenberg R, Wesnes KA, Walsh JK, Arora S, Niebler GE, Roth T.

Curr Med Res Opin. 2006 Apr;22(4):761-74.

PMID:
16684437
7.

Long-term efficacy and safety of modafinil (PROVIGIL((R))) for the treatment of excessive daytime sleepiness associated with narcolepsy.

Mitler MM, Harsh J, Hirshkowitz M, Guilleminault C.

Sleep Med. 2000 Jul 1;1(3):231-243.

PMID:
10828434
8.

Initiating treatment with modafinil for control of excessive daytime sleepiness in patients switching from methylphenidate: an open-label safety study assessing three strategies.

Thorpy MJ, Schwartz JR, Kovacevic-Ristanovic R, Hayduk R.

Psychopharmacology (Berl). 2003 Jun;167(4):380-5. Epub 2003 Apr 23.

PMID:
12709775
9.

Adjunct modafinil for the short-term treatment of fatigue and sleepiness in patients with major depressive disorder: a preliminary double-blind, placebo-controlled study.

DeBattista C, Doghramji K, Menza MA, Rosenthal MH, Fieve RR; Modafinil in Depression Study Group.

J Clin Psychiatry. 2003 Sep;64(9):1057-64.

PMID:
14628981
10.

Randomized, double-blind, placebo-controlled crossover trial of modafinil in the treatment of excessive daytime sleepiness in narcolepsy.

Broughton RJ, Fleming JA, George CF, Hill JD, Kryger MH, Moldofsky H, Montplaisir JY, Morehouse RL, Moscovitch A, Murphy WF.

Neurology. 1997 Aug;49(2):444-51.

PMID:
9270575
11.

Randomized trial of modafinil for treating subjective daytime sleepiness in patients with Parkinson's disease.

Adler CH, Caviness JN, Hentz JG, Lind M, Tiede J.

Mov Disord. 2003 Mar;18(3):287-93.

PMID:
12621632
12.
13.

Effect of modafinil on fatigue, mood, and health-related quality of life in patients with narcolepsy.

Becker PM, Schwartz JR, Feldman NT, Hughes RJ.

Psychopharmacology (Berl). 2004 Jan;171(2):133-9. Epub 2003 Nov 25.

PMID:
14647965
14.
15.

An open-label study of adjunctive modafinil in patients with sedation related to serotonergic antidepressant therapy.

Schwartz TL, Azhar N, Cole K, Hopkins G, Nihalani N, Simionescu M, Husain J, Jones N.

J Clin Psychiatry. 2004 Sep;65(9):1223-7.

PMID:
15367049
16.
17.

Modafinil for the treatment of daytime sleepiness in Parkinson's disease: a double-blind, randomized, crossover, placebo-controlled polygraphic trial.

Högl B, Saletu M, Brandauer E, Glatzl S, Frauscher B, Seppi K, Ulmer H, Wenning G, Poewe W.

Sleep. 2002 Dec;25(8):905-9.

PMID:
12489899

Supplemental Content

Support Center